These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9268189)

  • 21. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.
    Zhu Y; Bujo H; Yamazaki H; Ohwaki K; Jiang M; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
    Circ Res; 2004 Apr; 94(6):752-8. PubMed ID: 14764453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex expression of the genes coding for plasminogen activators and their inhibitors in HeLa-smooth muscle cell hybrids.
    Laug WE; Cao XR; T'Ang A; Pasquale S; Mundy R; Coensgen-Luna M; Weissman B
    Cell Growth Differ; 1992 Mar; 3(3):191-7. PubMed ID: 1633110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
    J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R; Torà M; Díaz VM; Real FX
    Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release of soluble urokinase receptor from vascular cells.
    Chavakis T; Willuweit AK; Lupu F; Preissner KT; Kanse SM
    Thromb Haemost; 2001 Aug; 86(2):686-93. PubMed ID: 11522023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
    Waghray A; Webber MM
    Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
    Laug WE
    Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
    Cullen JP; Nicholl SM; Sayeed S; Sitzmann JV; Okada SS; Cahill PA; Redmond EM
    Thromb Res; 2004; 114(1):57-65. PubMed ID: 15262486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion.
    Michaud-Levesque J; Demeule M; Béliveau R
    Exp Cell Res; 2005 Aug; 308(2):479-90. PubMed ID: 15936756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
    Webber MM; Waghray A
    Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.
    Sugiura Y; Ma L; Sun B; Shimada H; Laug WE; Seeger RC; DeClerck YA
    Cancer Res; 1999 Mar; 59(6):1327-36. PubMed ID: 10096567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
    Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
    Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
    Gundersen D; Trân-Thang C; Sordat B; Mourali F; Rüegg C
    J Immunol; 1997 Feb; 158(3):1051-60. PubMed ID: 9013942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration.
    Morimoto K; Mishima H; Nishida T; Otori T
    Thromb Haemost; 1993 Apr; 69(4):387-91. PubMed ID: 8497852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes.
    Kirchheimer JC; Remold HG
    J Immunol; 1989 Oct; 143(8):2634-9. PubMed ID: 2551965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pericellular plasmin induces smooth muscle cell anoikis.
    Meilhac O; Ho-Tin-Noé B; Houard X; Philippe M; Michel JB; Anglés-Cano E
    FASEB J; 2003 Jul; 17(10):1301-3. PubMed ID: 12738809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
    Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
    J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human tumor cell-associated fibrinolysis by vascular bovine smooth muscle cells.
    Laug WE
    J Natl Cancer Inst; 1985 Aug; 75(2):345-52. PubMed ID: 3860687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.